Evidence map›Paper›PMID 41141495›Full record

ArticleKidney international reports2025

Exome Sequencing in Saudi Arabian Pediatric Kidney Disease Single-Center Cohort.

Katharina Lemberg, Mohamed A Shalaby, Elena Zion, Ken Saida, Kirollos Yousef, Ronen Schneider, Nils D Mertens, Bshara Mansour, Caroline M Kolvenbach, Lea M Merz and 14 more

Abstract read
In one paragraph

Article in Kidney international reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Katharina LembergDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Mohamed A ShalabyPediatric Nephrology Center of Excellence, Department of Pediatrics, King Abdulaziz University, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Elena ZionDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Ken SaidaDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Kirollos YousefDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Ronen SchneiderDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Nils D MertensDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Bshara MansourDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Caroline M KolvenbachDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Lea M MerzDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Korbinian M RiedhammerDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Alina BraunDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Selina HölzelDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Seyoung YuDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Kraisoon LomjansookDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Gina KalkarDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Daniel MarchukDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Izzeldin ElmubarakDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Gijs A C FrankenDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Shirlee ShrilDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Sherif El DesokyPediatric Nephrology Center of Excellence, Department of Pediatrics, King Abdulaziz University, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Jameela A KariPediatric Nephrology Center of Excellence, Department of Pediatrics, King Abdulaziz University, King Abdulaziz University Hospital, Jeddah, Saudi Arabia.
Florian BuergerDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.
Friedhelm HildebrandtDivision of Nephrology, Boston Children's Hospital, HMS, Boston, Massachusetts, USA.

Funding

TRAINING GRANT IN GENETICST32GM007748 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Anne O'Donnell-Luria, Louise Wilkins-Haug · 1985 to 2026
$12.0M
RESEARCH TRAINING IN PEDIATRIC NEPHROLOGYT32DK007726 · NIDDK · CHILDREN'S HOSPITAL BOSTON · PI BRISCOE, DAVID M. · 1994 to 2023
$5.9M
NIDDK NIH HHS T32 DK007726NIGMS NIH HHS T32 GM007748
6 · The paper itself

Abstract

Introduction: In pediatric patients, monogenic causes are a significant contributor to kidney disease, ranging from approximately 10% in congenital anomalies of the kidney and urinary tract (CAKUT) to about 55% in renal ciliopathies. Exome sequencing has revealed numerous disease-causing genes and pathogenic variants. Nevertheless, continuous efforts are crucial to expand the knowledge base of these variants to establish unequivocal diagnoses. In this study, we report exome sequencing data from a single Saudi Arabian center, aiming to explore potential founder effects and determine specific genotype-phenotype correlations based on clinical diagnoses and genetic ancestry. Methods: We consolidated 487 families with glomerular disease, CAKUT, cystic kidney disease, stone disease, and tubulopathies, recruited between 2007 and 2023 at King Abdulaziz University in Jeddah, Saudi Arabia. In these families, we performed exome sequencing and analyzed the data obtained for variants in established disease genes. Results: In this highly consanguineous cohort (54%), 195 of 487 participants (40%) had glomerular disease, 160 of 487 (33%) had CAKUT, 44 of 487 (9%) had cystic kidney disease, 40 of 487 (8%) had stone disease, and 34 of 487 (7%) had tubulopathies. Pathogenic variants were identified in 45% of families with glomerular disease, 21% with CAKUT, 77% with cystic kidney disease, 58% with stone disease, and 76% of families with tubulopathy. Conclusion: We identified a likely genetic cause of kidney disease in 43% of participants. Elucidating prevalent disease genes and disease variants in a defined region and genetic ancestry group provides important insights into variant pathogenicity assessment, disease management, and prognosis.

Indexed as

congenital anomalies of the kidney and urinary tract (CAKUT)cystic kidney diseaseexome sequencingnephrotic syndromestone diseasetubulopathy

Identifiers

PMID41141495
PMCPMC12545823

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.